A hemodialysis (hd) user facility reported a dialyzer blood leak that occurred during a patients hd treatment.Additional information was obtained during follow up with the facilitys clinic manager (cm).The cm stated the blood leak occurred towards the end of the patients treatment, with less than ten minutes remaining.The blood leak was reported to be internal.The cm was not present at the time of the event did not know if the blood leak was visually observed.The machine, a fresenius 2008t, alarmed appropriately with a blood leak alert.Fresenius bloodlines were also being used.A blood test strip was used to test for the presence of blood, and it tested positive.There was no reported damage identified on the dialyzer.After the machine alarmed, the treatment was halted.The patients blood was not returned; estimated blood loss (ebl) was approximately 200 ml.The cm stated the patient did not complete their treatment.However, it was confirmed there was no patient injury, no adverse effects were experienced, and no medical intervention was required as a result of the reported event.The dialyzer was not available to be returned for evaluation as it was reportedly discarded after the event.
|
Plant investigation: the reported complaint was not confirmed as the complaint device was not returned for manufacturer evaluation.A production records review was performed on the reported lot.An investigation of the device history records (dhr) was conducted by the manufacturer.There was no indication of product nonacceptance, deviation, non-conformance, rework, labeling or process control failure during the manufacturing process which could be associated with the reported event.The lot met all release criteria.A definitive conclusion regarding the complaint incident cannot be reached without physical examination of the actual device.Therefore, the complaint is not confirmed.
|